nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—Tachycardia—Amitriptyline—migraine	0.00364	0.00364	CcSEcCtD
Deferoxamine—Neuropathy—Topiramate—migraine	0.00364	0.00364	CcSEcCtD
Deferoxamine—Renal failure acute—Gabapentin—migraine	0.00362	0.00362	CcSEcCtD
Deferoxamine—Cramps of lower extremities—Topiramate—migraine	0.00356	0.00356	CcSEcCtD
Deferoxamine—Renal impairment—Gabapentin—migraine	0.00351	0.00351	CcSEcCtD
Deferoxamine—Hypotension—Amitriptyline—migraine	0.00349	0.00349	CcSEcCtD
Deferoxamine—Eosinophilia—Valproic Acid—migraine	0.00345	0.00345	CcSEcCtD
Deferoxamine—Paraesthesia—Amitriptyline—migraine	0.00335	0.00335	CcSEcCtD
Deferoxamine—Abdominal discomfort—Valproic Acid—migraine	0.00334	0.00334	CcSEcCtD
Deferoxamine—Muscle spasms—Verapamil—migraine	0.0033	0.0033	CcSEcCtD
Deferoxamine—Dysuria—Valproic Acid—migraine	0.00326	0.00326	CcSEcCtD
Deferoxamine—Vision blurred—Verapamil—migraine	0.00323	0.00323	CcSEcCtD
Deferoxamine—Convulsion—Propranolol—migraine	0.00323	0.00323	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.00315	0.00315	CcSEcCtD
Deferoxamine—Blood creatinine increased—Gabapentin—migraine	0.00313	0.00313	CcSEcCtD
Deferoxamine—Angioedema—Verapamil—migraine	0.00313	0.00313	CcSEcCtD
Deferoxamine—Asthma—Timolol—migraine	0.0031	0.0031	CcSEcCtD
Deferoxamine—Anaphylactic shock—Propranolol—migraine	0.00304	0.00304	CcSEcCtD
Deferoxamine—Infection—Propranolol—migraine	0.00302	0.00302	CcSEcCtD
Deferoxamine—Nervous system disorder—Propranolol—migraine	0.00298	0.00298	CcSEcCtD
Deferoxamine—Visual disturbance—Topiramate—migraine	0.00297	0.00297	CcSEcCtD
Deferoxamine—Convulsion—Verapamil—migraine	0.00297	0.00297	CcSEcCtD
Deferoxamine—Urticaria—Amitriptyline—migraine	0.00297	0.00297	CcSEcCtD
Deferoxamine—Skin disorder—Propranolol—migraine	0.00295	0.00295	CcSEcCtD
Deferoxamine—Body temperature increased—Amitriptyline—migraine	0.00295	0.00295	CcSEcCtD
Deferoxamine—Arthralgia—Verapamil—migraine	0.00292	0.00292	CcSEcCtD
Deferoxamine—Myalgia—Verapamil—migraine	0.00292	0.00292	CcSEcCtD
Deferoxamine—Dysuria—Timolol—migraine	0.0029	0.0029	CcSEcCtD
Deferoxamine—Asthma—Gabapentin—migraine	0.00289	0.00289	CcSEcCtD
Deferoxamine—Eosinophilia—Gabapentin—migraine	0.00286	0.00286	CcSEcCtD
Deferoxamine—Bradycardia—Valproic Acid—migraine	0.00284	0.00284	CcSEcCtD
Deferoxamine—Anaphylactic shock—Verapamil—migraine	0.0028	0.0028	CcSEcCtD
Deferoxamine—Oedema—Verapamil—migraine	0.0028	0.0028	CcSEcCtD
Deferoxamine—Infection—Verapamil—migraine	0.00278	0.00278	CcSEcCtD
Deferoxamine—Hallucination—Valproic Acid—migraine	0.00278	0.00278	CcSEcCtD
Deferoxamine—Urinary tract disorder—Valproic Acid—migraine	0.00276	0.00276	CcSEcCtD
Deferoxamine—Shock—Verapamil—migraine	0.00275	0.00275	CcSEcCtD
Deferoxamine—Connective tissue disorder—Valproic Acid—migraine	0.00274	0.00274	CcSEcCtD
Deferoxamine—Urethral disorder—Valproic Acid—migraine	0.00274	0.00274	CcSEcCtD
Deferoxamine—Paraesthesia—Propranolol—migraine	0.00273	0.00273	CcSEcCtD
Deferoxamine—Tachycardia—Verapamil—migraine	0.00273	0.00273	CcSEcCtD
Deferoxamine—Dyspnoea—Propranolol—migraine	0.00271	0.00271	CcSEcCtD
Deferoxamine—Dysuria—Gabapentin—migraine	0.0027	0.0027	CcSEcCtD
Deferoxamine—Visual impairment—Valproic Acid—migraine	0.00269	0.00269	CcSEcCtD
Deferoxamine—Pruritus—Amitriptyline—migraine	0.00264	0.00264	CcSEcCtD
Deferoxamine—Blood creatinine increased—Topiramate—migraine	0.00264	0.00264	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Propranolol—migraine	0.00263	0.00263	CcSEcCtD
Deferoxamine—Hypotension—Verapamil—migraine	0.00261	0.00261	CcSEcCtD
Deferoxamine—Eye disorder—Valproic Acid—migraine	0.00261	0.00261	CcSEcCtD
Deferoxamine—Tinnitus—Valproic Acid—migraine	0.0026	0.0026	CcSEcCtD
Deferoxamine—Pain—Propranolol—migraine	0.0026	0.0026	CcSEcCtD
Deferoxamine—Infestation NOS—Gabapentin—migraine	0.00258	0.00258	CcSEcCtD
Deferoxamine—Infestation—Gabapentin—migraine	0.00258	0.00258	CcSEcCtD
Deferoxamine—Diarrhoea—Amitriptyline—migraine	0.00256	0.00256	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Verapamil—migraine	0.00255	0.00255	CcSEcCtD
Deferoxamine—Renal failure—Gabapentin—migraine	0.00253	0.00253	CcSEcCtD
Deferoxamine—Angiopathy—Valproic Acid—migraine	0.00253	0.00253	CcSEcCtD
Deferoxamine—Bradycardia—Timolol—migraine	0.00253	0.00253	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Gabapentin—migraine	0.00253	0.00253	CcSEcCtD
Deferoxamine—Immune system disorder—Valproic Acid—migraine	0.00252	0.00252	CcSEcCtD
Deferoxamine—Mediastinal disorder—Valproic Acid—migraine	0.00252	0.00252	CcSEcCtD
Deferoxamine—Paraesthesia—Verapamil—migraine	0.00251	0.00251	CcSEcCtD
Deferoxamine—Arrhythmia—Valproic Acid—migraine	0.00249	0.00249	CcSEcCtD
Deferoxamine—Dyspnoea—Verapamil—migraine	0.00249	0.00249	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Propranolol—migraine	0.00249	0.00249	CcSEcCtD
Deferoxamine—Hallucination—Timolol—migraine	0.00247	0.00247	CcSEcCtD
Deferoxamine—Dizziness—Amitriptyline—migraine	0.00247	0.00247	CcSEcCtD
Deferoxamine—Connective tissue disorder—Timolol—migraine	0.00244	0.00244	CcSEcCtD
Deferoxamine—Asthma—Topiramate—migraine	0.00243	0.00243	CcSEcCtD
Deferoxamine—Urticaria—Propranolol—migraine	0.00242	0.00242	CcSEcCtD
Deferoxamine—Eosinophilia—Topiramate—migraine	0.00241	0.00241	CcSEcCtD
Deferoxamine—Abdominal pain—Propranolol—migraine	0.0024	0.0024	CcSEcCtD
Deferoxamine—Body temperature increased—Propranolol—migraine	0.0024	0.0024	CcSEcCtD
Deferoxamine—Visual impairment—Timolol—migraine	0.00239	0.00239	CcSEcCtD
Deferoxamine—Pain—Verapamil—migraine	0.00239	0.00239	CcSEcCtD
Deferoxamine—Vomiting—Amitriptyline—migraine	0.00237	0.00237	CcSEcCtD
Deferoxamine—Bradycardia—Gabapentin—migraine	0.00236	0.00236	CcSEcCtD
Deferoxamine—Headache—Amitriptyline—migraine	0.00234	0.00234	CcSEcCtD
Deferoxamine—Muscle spasms—Valproic Acid—migraine	0.00234	0.00234	CcSEcCtD
Deferoxamine—Abdominal discomfort—Topiramate—migraine	0.00233	0.00233	CcSEcCtD
Deferoxamine—Eye disorder—Timolol—migraine	0.00232	0.00232	CcSEcCtD
Deferoxamine—Tinnitus—Timolol—migraine	0.00232	0.00232	CcSEcCtD
Deferoxamine—Hallucination—Gabapentin—migraine	0.0023	0.0023	CcSEcCtD
Deferoxamine—Vision blurred—Valproic Acid—migraine	0.00229	0.00229	CcSEcCtD
Deferoxamine—Urinary tract disorder—Gabapentin—migraine	0.00229	0.00229	CcSEcCtD
Deferoxamine—Dysuria—Topiramate—migraine	0.00227	0.00227	CcSEcCtD
Deferoxamine—Connective tissue disorder—Gabapentin—migraine	0.00227	0.00227	CcSEcCtD
Deferoxamine—Urethral disorder—Gabapentin—migraine	0.00227	0.00227	CcSEcCtD
Deferoxamine—Angiopathy—Timolol—migraine	0.00225	0.00225	CcSEcCtD
Deferoxamine—Immune system disorder—Timolol—migraine	0.00224	0.00224	CcSEcCtD
Deferoxamine—Hypersensitivity—Propranolol—migraine	0.00224	0.00224	CcSEcCtD
Deferoxamine—Mediastinal disorder—Timolol—migraine	0.00224	0.00224	CcSEcCtD
Deferoxamine—Visual impairment—Gabapentin—migraine	0.00223	0.00223	CcSEcCtD
Deferoxamine—Urticaria—Verapamil—migraine	0.00222	0.00222	CcSEcCtD
Deferoxamine—Angioedema—Valproic Acid—migraine	0.00222	0.00222	CcSEcCtD
Deferoxamine—Arrhythmia—Timolol—migraine	0.00222	0.00222	CcSEcCtD
Deferoxamine—Nausea—Amitriptyline—migraine	0.00222	0.00222	CcSEcCtD
Deferoxamine—Leukopenia—Valproic Acid—migraine	0.00218	0.00218	CcSEcCtD
Deferoxamine—Infestation—Topiramate—migraine	0.00217	0.00217	CcSEcCtD
Deferoxamine—Infestation NOS—Topiramate—migraine	0.00217	0.00217	CcSEcCtD
Deferoxamine—Erythema—Timolol—migraine	0.00216	0.00216	CcSEcCtD
Deferoxamine—Eye disorder—Gabapentin—migraine	0.00216	0.00216	CcSEcCtD
Deferoxamine—Tinnitus—Gabapentin—migraine	0.00216	0.00216	CcSEcCtD
Deferoxamine—Renal failure—Topiramate—migraine	0.00213	0.00213	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Topiramate—migraine	0.00213	0.00213	CcSEcCtD
Deferoxamine—Immune system disorder—Gabapentin—migraine	0.00209	0.00209	CcSEcCtD
Deferoxamine—Mediastinal disorder—Gabapentin—migraine	0.00209	0.00209	CcSEcCtD
Deferoxamine—Diarrhoea—Propranolol—migraine	0.00208	0.00208	CcSEcCtD
Deferoxamine—Arthralgia—Valproic Acid—migraine	0.00207	0.00207	CcSEcCtD
Deferoxamine—Myalgia—Valproic Acid—migraine	0.00207	0.00207	CcSEcCtD
Deferoxamine—Hypersensitivity—Verapamil—migraine	0.00206	0.00206	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.00205	0.00205	CcSEcCtD
Deferoxamine—Vision blurred—Timolol—migraine	0.00204	0.00204	CcSEcCtD
Deferoxamine—Erythema—Gabapentin—migraine	0.00201	0.00201	CcSEcCtD
Deferoxamine—Dizziness—Propranolol—migraine	0.00201	0.00201	CcSEcCtD
Deferoxamine—Anaphylactic shock—Valproic Acid—migraine	0.00198	0.00198	CcSEcCtD
Deferoxamine—Oedema—Valproic Acid—migraine	0.00198	0.00198	CcSEcCtD
Deferoxamine—Bradycardia—Topiramate—migraine	0.00198	0.00198	CcSEcCtD
Deferoxamine—Pruritus—Verapamil—migraine	0.00198	0.00198	CcSEcCtD
Deferoxamine—Angioedema—Timolol—migraine	0.00198	0.00198	CcSEcCtD
Deferoxamine—Infection—Valproic Acid—migraine	0.00197	0.00197	CcSEcCtD
Deferoxamine—Nervous system disorder—Valproic Acid—migraine	0.00194	0.00194	CcSEcCtD
Deferoxamine—Thrombocytopenia—Valproic Acid—migraine	0.00194	0.00194	CcSEcCtD
Deferoxamine—Hallucination—Topiramate—migraine	0.00194	0.00194	CcSEcCtD
Deferoxamine—Muscle spasms—Gabapentin—migraine	0.00194	0.00194	CcSEcCtD
Deferoxamine—Tachycardia—Valproic Acid—migraine	0.00194	0.00194	CcSEcCtD
Deferoxamine—Vomiting—Propranolol—migraine	0.00193	0.00193	CcSEcCtD
Deferoxamine—Skin disorder—Valproic Acid—migraine	0.00193	0.00193	CcSEcCtD
Deferoxamine—Urinary tract disorder—Topiramate—migraine	0.00192	0.00192	CcSEcCtD
Deferoxamine—Diarrhoea—Verapamil—migraine	0.00191	0.00191	CcSEcCtD
Deferoxamine—Connective tissue disorder—Topiramate—migraine	0.00191	0.00191	CcSEcCtD
Deferoxamine—Urethral disorder—Topiramate—migraine	0.00191	0.00191	CcSEcCtD
Deferoxamine—Vision blurred—Gabapentin—migraine	0.0019	0.0019	CcSEcCtD
Deferoxamine—Visual impairment—Topiramate—migraine	0.00188	0.00188	CcSEcCtD
Deferoxamine—Hypotension—Valproic Acid—migraine	0.00185	0.00185	CcSEcCtD
Deferoxamine—Dizziness—Verapamil—migraine	0.00185	0.00185	CcSEcCtD
Deferoxamine—Arthralgia—Timolol—migraine	0.00184	0.00184	CcSEcCtD
Deferoxamine—Myalgia—Timolol—migraine	0.00184	0.00184	CcSEcCtD
Deferoxamine—Angioedema—Gabapentin—migraine	0.00184	0.00184	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.00183	0.00183	CcSEcCtD
Deferoxamine—Eye disorder—Topiramate—migraine	0.00182	0.00182	CcSEcCtD
Deferoxamine—Tinnitus—Topiramate—migraine	0.00182	0.00182	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Valproic Acid—migraine	0.00181	0.00181	CcSEcCtD
Deferoxamine—Nausea—Propranolol—migraine	0.00181	0.00181	CcSEcCtD
Deferoxamine—Leukopenia—Gabapentin—migraine	0.0018	0.0018	CcSEcCtD
Deferoxamine—Paraesthesia—Valproic Acid—migraine	0.00178	0.00178	CcSEcCtD
Deferoxamine—Vomiting—Verapamil—migraine	0.00178	0.00178	CcSEcCtD
Deferoxamine—Dyspnoea—Valproic Acid—migraine	0.00177	0.00177	CcSEcCtD
Deferoxamine—Angiopathy—Topiramate—migraine	0.00177	0.00177	CcSEcCtD
Deferoxamine—Anaphylactic shock—Timolol—migraine	0.00177	0.00177	CcSEcCtD
Deferoxamine—Oedema—Timolol—migraine	0.00177	0.00177	CcSEcCtD
Deferoxamine—Immune system disorder—Topiramate—migraine	0.00176	0.00176	CcSEcCtD
Deferoxamine—Mediastinal disorder—Topiramate—migraine	0.00175	0.00175	CcSEcCtD
Deferoxamine—Infection—Timolol—migraine	0.00175	0.00175	CcSEcCtD
Deferoxamine—Headache—Verapamil—migraine	0.00175	0.00175	CcSEcCtD
Deferoxamine—Convulsion—Gabapentin—migraine	0.00175	0.00175	CcSEcCtD
Deferoxamine—Shock—Timolol—migraine	0.00174	0.00174	CcSEcCtD
Deferoxamine—Nervous system disorder—Timolol—migraine	0.00173	0.00173	CcSEcCtD
Deferoxamine—Myalgia—Gabapentin—migraine	0.00172	0.00172	CcSEcCtD
Deferoxamine—Arthralgia—Gabapentin—migraine	0.00172	0.00172	CcSEcCtD
Deferoxamine—Skin disorder—Timolol—migraine	0.00171	0.00171	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Valproic Acid—migraine	0.00171	0.00171	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.0017	0.0017	CcSEcCtD
Deferoxamine—Pain—Valproic Acid—migraine	0.0017	0.0017	CcSEcCtD
Deferoxamine—Erythema—Topiramate—migraine	0.00169	0.00169	CcSEcCtD
Deferoxamine—Nausea—Verapamil—migraine	0.00166	0.00166	CcSEcCtD
Deferoxamine—Hypotension—Timolol—migraine	0.00165	0.00165	CcSEcCtD
Deferoxamine—Oedema—Gabapentin—migraine	0.00164	0.00164	CcSEcCtD
Deferoxamine—Anaphylactic shock—Gabapentin—migraine	0.00164	0.00164	CcSEcCtD
Deferoxamine—Infection—Gabapentin—migraine	0.00163	0.00163	CcSEcCtD
Deferoxamine—Muscle spasms—Topiramate—migraine	0.00163	0.00163	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Valproic Acid—migraine	0.00162	0.00162	CcSEcCtD
Deferoxamine—Shock—Gabapentin—migraine	0.00162	0.00162	CcSEcCtD
Deferoxamine—Nervous system disorder—Gabapentin—migraine	0.00161	0.00161	CcSEcCtD
Deferoxamine—Thrombocytopenia—Gabapentin—migraine	0.00161	0.00161	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Timolol—migraine	0.00161	0.00161	CcSEcCtD
Deferoxamine—Tachycardia—Gabapentin—migraine	0.0016	0.0016	CcSEcCtD
Deferoxamine—Vision blurred—Topiramate—migraine	0.0016	0.0016	CcSEcCtD
Deferoxamine—Skin disorder—Gabapentin—migraine	0.0016	0.0016	CcSEcCtD
Deferoxamine—Paraesthesia—Timolol—migraine	0.00159	0.00159	CcSEcCtD
Deferoxamine—Urticaria—Valproic Acid—migraine	0.00158	0.00158	CcSEcCtD
Deferoxamine—Dyspnoea—Timolol—migraine	0.00157	0.00157	CcSEcCtD
Deferoxamine—Body temperature increased—Valproic Acid—migraine	0.00157	0.00157	CcSEcCtD
Deferoxamine—Abdominal pain—Valproic Acid—migraine	0.00157	0.00157	CcSEcCtD
Deferoxamine—Hypotension—Gabapentin—migraine	0.00154	0.00154	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Timolol—migraine	0.00152	0.00152	CcSEcCtD
Deferoxamine—Leukopenia—Topiramate—migraine	0.00152	0.00152	CcSEcCtD
Deferoxamine—Pain—Timolol—migraine	0.00151	0.00151	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Gabapentin—migraine	0.0015	0.0015	CcSEcCtD
Deferoxamine—Paraesthesia—Gabapentin—migraine	0.00148	0.00148	CcSEcCtD
Deferoxamine—Convulsion—Topiramate—migraine	0.00147	0.00147	CcSEcCtD
Deferoxamine—Dyspnoea—Gabapentin—migraine	0.00147	0.00147	CcSEcCtD
Deferoxamine—Hypersensitivity—Valproic Acid—migraine	0.00146	0.00146	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Timolol—migraine	0.00144	0.00144	CcSEcCtD
Deferoxamine—Arthralgia—Topiramate—migraine	0.00144	0.00144	CcSEcCtD
Deferoxamine—Myalgia—Topiramate—migraine	0.00144	0.00144	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.00143	0.00143	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Gabapentin—migraine	0.00142	0.00142	CcSEcCtD
Deferoxamine—Pain—Gabapentin—migraine	0.00141	0.00141	CcSEcCtD
Deferoxamine—Pruritus—Valproic Acid—migraine	0.0014	0.0014	CcSEcCtD
Deferoxamine—Urticaria—Timolol—migraine	0.0014	0.0014	CcSEcCtD
Deferoxamine—Abdominal pain—Timolol—migraine	0.0014	0.0014	CcSEcCtD
Deferoxamine—Body temperature increased—Timolol—migraine	0.0014	0.0014	CcSEcCtD
Deferoxamine—Oedema—Topiramate—migraine	0.00138	0.00138	CcSEcCtD
Deferoxamine—Infection—Topiramate—migraine	0.00137	0.00137	CcSEcCtD
Deferoxamine—Shock—Topiramate—migraine	0.00136	0.00136	CcSEcCtD
Deferoxamine—Diarrhoea—Valproic Acid—migraine	0.00136	0.00136	CcSEcCtD
Deferoxamine—Nervous system disorder—Topiramate—migraine	0.00136	0.00136	CcSEcCtD
Deferoxamine—Thrombocytopenia—Topiramate—migraine	0.00135	0.00135	CcSEcCtD
Deferoxamine—Tachycardia—Topiramate—migraine	0.00135	0.00135	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Gabapentin—migraine	0.00134	0.00134	CcSEcCtD
Deferoxamine—Skin disorder—Topiramate—migraine	0.00134	0.00134	CcSEcCtD
Deferoxamine—Dizziness—Valproic Acid—migraine	0.00131	0.00131	CcSEcCtD
Deferoxamine—Urticaria—Gabapentin—migraine	0.00131	0.00131	CcSEcCtD
Deferoxamine—Hypersensitivity—Timolol—migraine	0.0013	0.0013	CcSEcCtD
Deferoxamine—Body temperature increased—Gabapentin—migraine	0.0013	0.0013	CcSEcCtD
Deferoxamine—Abdominal pain—Gabapentin—migraine	0.0013	0.0013	CcSEcCtD
Deferoxamine—Hypotension—Topiramate—migraine	0.00129	0.00129	CcSEcCtD
Deferoxamine—Vomiting—Valproic Acid—migraine	0.00126	0.00126	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Topiramate—migraine	0.00126	0.00126	CcSEcCtD
Deferoxamine—Pruritus—Timolol—migraine	0.00125	0.00125	CcSEcCtD
Deferoxamine—Headache—Valproic Acid—migraine	0.00124	0.00124	CcSEcCtD
Deferoxamine—Paraesthesia—Topiramate—migraine	0.00124	0.00124	CcSEcCtD
Deferoxamine—Dyspnoea—Topiramate—migraine	0.00123	0.00123	CcSEcCtD
Deferoxamine—Hypersensitivity—Gabapentin—migraine	0.00121	0.00121	CcSEcCtD
Deferoxamine—Diarrhoea—Timolol—migraine	0.00121	0.00121	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Topiramate—migraine	0.00119	0.00119	CcSEcCtD
Deferoxamine—Pain—Topiramate—migraine	0.00118	0.00118	CcSEcCtD
Deferoxamine—Nausea—Valproic Acid—migraine	0.00118	0.00118	CcSEcCtD
Deferoxamine—Dizziness—Timolol—migraine	0.00117	0.00117	CcSEcCtD
Deferoxamine—Pruritus—Gabapentin—migraine	0.00116	0.00116	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Topiramate—migraine	0.00113	0.00113	CcSEcCtD
Deferoxamine—Diarrhoea—Gabapentin—migraine	0.00112	0.00112	CcSEcCtD
Deferoxamine—Vomiting—Timolol—migraine	0.00112	0.00112	CcSEcCtD
Deferoxamine—Headache—Timolol—migraine	0.00111	0.00111	CcSEcCtD
Deferoxamine—Urticaria—Topiramate—migraine	0.0011	0.0011	CcSEcCtD
Deferoxamine—Abdominal pain—Topiramate—migraine	0.00109	0.00109	CcSEcCtD
Deferoxamine—Body temperature increased—Topiramate—migraine	0.00109	0.00109	CcSEcCtD
Deferoxamine—Dizziness—Gabapentin—migraine	0.00109	0.00109	CcSEcCtD
Deferoxamine—Nausea—Timolol—migraine	0.00105	0.00105	CcSEcCtD
Deferoxamine—Vomiting—Gabapentin—migraine	0.00105	0.00105	CcSEcCtD
Deferoxamine—Headache—Gabapentin—migraine	0.00103	0.00103	CcSEcCtD
Deferoxamine—Hypersensitivity—Topiramate—migraine	0.00102	0.00102	CcSEcCtD
Deferoxamine—Pruritus—Topiramate—migraine	0.000979	0.000979	CcSEcCtD
Deferoxamine—Nausea—Gabapentin—migraine	0.000977	0.000977	CcSEcCtD
Deferoxamine—Diarrhoea—Topiramate—migraine	0.000946	0.000946	CcSEcCtD
Deferoxamine—Dizziness—Topiramate—migraine	0.000915	0.000915	CcSEcCtD
Deferoxamine—Vomiting—Topiramate—migraine	0.000879	0.000879	CcSEcCtD
Deferoxamine—Headache—Topiramate—migraine	0.000867	0.000867	CcSEcCtD
Deferoxamine—Nausea—Topiramate—migraine	0.000822	0.000822	CcSEcCtD
